FibroBiologics, Inc. (FBLG) stock
FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.93−0.04 (-4.21%)
Close on Nov 13, 2026Market cap $6.17MP/E –Yield –
FibroBiologics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
FibroBiologics's enterprise value was $271.04K on Nov 11, 2026, against $5.58M a year earlier. Over the last 3 years it ranged from -$1.95M to $819.25M, with a median of $13.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $271.04K | -92.7% |
| 2025 | Dec 31, 2025 | $3.71M | -93.3% |
| 2024 | Dec 31, 2024 | $54.97M | – |
See a number that looks wrong?